HK1009931A1 - Combination pediatric vaccine with enhanced immunogenicity of each vaccine component - Google Patents

Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Info

Publication number
HK1009931A1
HK1009931A1 HK98110626A HK98110626A HK1009931A1 HK 1009931 A1 HK1009931 A1 HK 1009931A1 HK 98110626 A HK98110626 A HK 98110626A HK 98110626 A HK98110626 A HK 98110626A HK 1009931 A1 HK1009931 A1 HK 1009931A1
Authority
HK
Hong Kong
Prior art keywords
vaccine
enhanced immunogenicity
component
combined
pediatric
Prior art date
Application number
HK98110626A
Other languages
English (en)
Inventor
Peter R Paradiso
Deborah A Hogerman
Dace Viceps Madore
Jill G Hackell
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of HK1009931A1 publication Critical patent/HK1009931A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Peptides Or Proteins (AREA)
HK98110626A 1992-10-27 1998-09-14 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component HK1009931A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (1)

Publication Number Publication Date
HK1009931A1 true HK1009931A1 (en) 1999-06-11

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110626A HK1009931A1 (en) 1992-10-27 1998-09-14 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Country Status (23)

Country Link
EP (1) EP0594950B1 (uk)
JP (1) JPH07300427A (uk)
KR (1) KR100289224B1 (uk)
AT (1) ATE176157T1 (uk)
AU (1) AU669570B2 (uk)
CA (1) CA2109159A1 (uk)
CZ (1) CZ283587B6 (uk)
DE (2) DE69323264D1 (uk)
DK (1) DK0594950T3 (uk)
ES (1) ES2126616T3 (uk)
FI (1) FI934725A (uk)
GR (1) GR3029884T3 (uk)
HK (1) HK1009931A1 (uk)
HU (1) HU215149B (uk)
IL (1) IL107387A (uk)
LV (1) LV12271B (uk)
NO (1) NO308588B1 (uk)
NZ (1) NZ250029A (uk)
PL (1) PL174130B1 (uk)
RU (1) RU2121365C1 (uk)
SG (1) SG47725A1 (uk)
TW (1) TW256774B (uk)
UA (1) UA27754C2 (uk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024216A1 (en) * 1994-03-07 1995-09-14 Auckland Uniservices Limited Prevention of diabetes
ATE400295T1 (de) * 1995-06-07 2008-07-15 Glaxosmithkline Biolog Sa Vakzine mit einem polysaccharide antigen- trägerprotein konjugat und freiem trägerprotein
CN1146444C (zh) * 1995-06-23 2004-04-21 史密斯克莱·比奇曼生物公司 含有吸附于磷酸铝上的多糖偶联抗原的疫苗组合物
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
JP3280675B2 (ja) * 1996-07-02 2002-05-13 コノート ラボラトリーズ リミテッド 多価ｄｔｐポリオワクチン
CA2783274C (en) * 2000-06-29 2018-08-07 Glaxosmithkline Biologicals S.A. Multivalent vaccine composition with reduced dose of haemophilus influenza type b
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
WO2004039417A2 (en) 2002-11-01 2004-05-13 Glaxosmithkline Biologicals S.A. Drying process
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
MX2007016403A (es) 2005-06-27 2008-03-07 Glaxosmithkline Biolog Sa Composicion inmunogenica.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates

Also Published As

Publication number Publication date
NO933856D0 (no) 1993-10-26
FI934725A (fi) 1994-04-28
KR940008698A (ko) 1994-05-16
DE69323264D1 (de) 1999-03-11
DK0594950T3 (da) 1999-09-13
UA27754C2 (uk) 2000-10-16
CZ283587B6 (cs) 1998-05-13
GR3029884T3 (en) 1999-07-30
HUT67239A (en) 1995-03-28
SG47725A1 (en) 1998-04-17
AU5029093A (en) 1994-05-12
DE69323264T4 (de) 1999-10-14
IL107387A0 (en) 1994-01-25
HU215149B (hu) 2000-03-28
NO933856L (no) 1994-04-28
HU9303028D0 (en) 1994-01-28
CZ227293A3 (en) 1994-05-18
ATE176157T1 (de) 1999-02-15
TW256774B (uk) 1995-09-11
ES2126616T3 (es) 1999-04-01
RU2121365C1 (ru) 1998-11-10
NO308588B1 (no) 2000-10-02
AU669570B2 (en) 1996-06-13
CA2109159A1 (en) 1994-04-28
LV12271A (lv) 1999-05-20
NZ250029A (en) 1994-09-27
LV12271B (en) 1999-07-20
DE69323264T2 (de) 1999-06-02
KR100289224B1 (ko) 2001-05-02
PL174130B1 (pl) 1998-06-30
EP0594950B1 (en) 1999-01-27
FI934725A0 (fi) 1993-10-26
EP0594950A1 (en) 1994-05-04
IL107387A (en) 1997-04-15
JPH07300427A (ja) 1995-11-14

Similar Documents

Publication Publication Date Title
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
CA2198251A1 (en) Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
HK1055244A1 (en) Multivalent vaccine composition
HU913103D0 (en) Method for producing vaccines of oligosacharide conjugates
WO1989006974A3 (en) T-cell epitope as carriers molecule for conjugate vaccines
HUT67239A (en) Combination pediatric vaccine with enhanced immunogenicity of each vaccine component
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
EP0338265A3 (en) Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine
WO1997035613A1 (en) Method of producing immunogenic products and vaccines
Audibert et al. Of antigens, adjuvants, and carriers in synthetic vaccines.
Egorkov et al. Immunological activity of small doses of diphtheria and tetanus toxoids in booster immunization of children with allergically altered responsiveness and adults.
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)